Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Circulating tumor-derived mutant mitochondrial DNA: a predictive biomarker of clinical prognosis in human squamous cell carcinoma.

Oncotarget - 1 Jul 2012

Uzawa Katsuhiro, Baba Takao, Uchida Fumihiko, Yamatoji Masanobu, Kasamatsu Atsushi, Sakamoto Yosuke, Ogawara Katsunori, Shiiba Masashi, Bukawa Hiroki, Tanzawa Hideki

Abstract excerpt

While circulating tumor-derived molecules have been identified in a variety of malignant tumors, it is sometimes difficult to detect the molecular targets due to the lower serum concentration. We report that evaluation of circulating tumor-derived mitochondrial DNA (mtDNA) seems to have novel eff...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Carcinoma, Squamous Cell

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cell Line, Tumor

Share to DNA, Mitochondrial

Share to Mice, Inbred BALB C

Share to Mouth Neoplasms

Share to Prognosis

Source

Open in PubMed Open full text

Identifiers

PMID: 22832574
DOI: 10.18632/oncotarget.523
PMCID: PMC3443250

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-22832574-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Circulating tumor-derived mutant mitochondrial DNA: a predictive biomarker of clinical prognosis in human squamous cell carcinoma.PMID 22832574Read ↗

Quantitative detection of circulating tumor-derived mitochondrial NADH subunit variants as a potential prognostic biomarker for oral cancer.Semantic proximity Read ↗

Mitochondrial DNA mutation in normal margins and tumors of recurrent head and neck squamous cell carcinoma patients.Semantic proximity Read ↗

Longitudinal Monitoring of Circulating Tumor DNA From Plasma in Patients With Curative Resected Stages I to IIIA EGFR-Mutant Non-Small Cell Lung Cancer.Semantic proximity Read ↗

Intratumoral Heterogeneity in Recurrent Metastatic Squamous Cell Carcinoma of the Oral Cavity: New Perspectives Afforded by Multiregion DNA Sequencing and mtDNA AnalysisSemantic proximity Read ↗

Low copy number of mitochondrial DNA (mtDNA) predicts worse prognosis in early-stage laryngeal cancer patientsSemantic proximity Read ↗

Impact of somatic mutations in the D-loop of mitochondrial DNA on the survival of oral squamous cell carcinoma patients.Semantic proximity Read ↗

Hypermethylated RASSF1A as Circulating Tumor DNA Marker for Disease Monitoring in NeuroblastomaSemantic proximity Read ↗

Salivary-Based Cell-Free Mitochondrial DNA Level Is an Independent Prognostic Biomarker for Patients with Head and Neck Squamous Cell CarcinomaSemantic proximity Read ↗

Plasma DNA, microsatellite alterations, and p53 tumor mutations are associated with disease-free survival in radically resected non-small cell lung cancer patients: a study of the perugia multidisciplinary team for thoracic oncology.Semantic proximity Read ↗

Post surgery circulating free tumor DNA is a predictive biomarker for relapse of lung cancer.Semantic proximity Read ↗

Validation of Next-Generation Sequencing of Entire Mitochondrial Genomes and the Diversity of Mitochondrial DNA Mutations in Oral Squamous Cell Carcinoma.Semantic proximity Read ↗

Mitochondrial DNA mutations in head and neck cancer are infrequent and lack prognostic utility.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.